Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Wells

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 monthsAvinash K Shetty, Hoosen M Coovadia, Mark M Mirochnick, et al.
The American Journal of Psychiatry|September 3, 2009
The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up, John March, Susan Silva, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 monthsAvinash K Shetty, Hoosen M Coovadia, Mark M Mirochnick, et al.
The American Journal of Psychiatry|September 3, 2009
The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up, John March, Susan Silva, et al.
Pageof 4